Impact of Programmed Death-ligand 1 Expression on Oncological Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Radiation-based Therapy

BACKGROUND: No biomarkers are recommended for patients undergoing radiation-based therapy (RT) for muscle-invasive bladder cancer (MIBC). OBJECTIVE: We aim to evaluate the predictive role of programmed death-ligand 1 (PD-L1) expression on the oncological outcomes of patients treated with RT for MIBC...

Descripción completa

Detalles Bibliográficos
Autores principales: Marcq, Gautier, Evaristo, Gertruda, Kool, Ronald, Shinde-Jadhav, Surashri, Skowronski, Rodrigo, Mansure, José João, Souhami, Luis, Cury, Fabio, Brimo, Fadi, Kassouf, Wassim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Urothelial Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638761/
https://www.ncbi.nlm.nih.gov/pubmed/36353066
http://dx.doi.org/10.1016/j.euros.2022.06.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638761/
https://www.ncbi.nlm.nih.gov/pubmed/36353066
http://dx.doi.org/10.1016/j.euros.2022.06.009

Ejemplares similares